GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Danapha Pharmaceutical JSC (HSTC:DAN) » Definitions » Liabilities-to-Assets

Danapha Pharmaceutical JSC (HSTC:DAN) Liabilities-to-Assets : 0.00 (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is Danapha Pharmaceutical JSC Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Danapha Pharmaceutical JSC's Total Liabilities for the quarter that ended in . 20 was ₫0.00 Mil. Danapha Pharmaceutical JSC's Total Assets for the quarter that ended in . 20 was ₫0.00 Mil.


Danapha Pharmaceutical JSC Liabilities-to-Assets Historical Data

The historical data trend for Danapha Pharmaceutical JSC's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danapha Pharmaceutical JSC Liabilities-to-Assets Chart

Danapha Pharmaceutical JSC Annual Data
Trend
Liabilities-to-Assets

Danapha Pharmaceutical JSC Semi-Annual Data
Liabilities-to-Assets

Competitive Comparison of Danapha Pharmaceutical JSC's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Danapha Pharmaceutical JSC's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danapha Pharmaceutical JSC's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Danapha Pharmaceutical JSC's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Danapha Pharmaceutical JSC's Liabilities-to-Assets falls into.


;
;

Danapha Pharmaceutical JSC Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Danapha Pharmaceutical JSC's Liabilities-to-Assets Ratio for the fiscal year that ended in . 20 is calculated as:

Liabilities-to-Assets (A: . 20 )=Total Liabilities/Total Assets
=/
=N/A

Danapha Pharmaceutical JSC's Liabilities-to-Assets Ratio for the quarter that ended in . 20 is calculated as

Liabilities-to-Assets (Q: . 20 )=Total Liabilities/Total Assets
=/
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Danapha Pharmaceutical JSC  (HSTC:DAN) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Danapha Pharmaceutical JSC Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Danapha Pharmaceutical JSC's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Danapha Pharmaceutical JSC Business Description

Traded in Other Exchanges
N/A
Address
253 Dung Si Thanh Khe, Da Nang, VNM
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.